Archivserver der Deutschen Nationalbibliothek

107. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G,
Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N,
Briguori C, Gerckens U, Grube E, Colombo A. Incidence, predictors, and
outcome of thrombosis after successful implantation of drug-eluting
stents. Jama. 2005; 293:2126-30.
108. Cagiannos C, Abul-Khoudoud OR, DeRijk W, Shell DHt, Jennings LK,
Tolley EA, Handorf CR, Fabian TC. Rapamycin-coated expanded
polytetrafluoroethylene bypass grafts exhibit decreased anastomotic
neointimal hyperplasia in a porcine model. J Vasc Surg. 2005; 42:980-8.
109. Vert M, Li S, Garreau H. New insights on the degradation of
bioresorbable polymeric devices based on lactic and glycolic acids. Clin
Mater. 1992; 10:3-8.
110. Hietala EM, Salminen US, Stahls A, Valimaa T, Maasilta P, Tormala P,
Nieminen MS, Harjula AL. Biodegradation of the copolymeric
polylactide stent. Long-term follow-up in a rabbit aorta model. J Vasc
Res. 2001; 38:361-9.
111. Furman MI, Frelinger IA, Michelson AD. Antithrombotic therapy in the
cardiac catheterization laboratory: focus on antiplatelet agents. Curr
Cardiol Rep. 2000; 2:386-94.
112. Schomig A, Neumann FJ, Kastrati A, Schuhlen H, Blasini R, Hadamitzky
M, Walter H, Zitzmann-Roth EM, Richardt G, Alt E, Schmitt C, Ulm K.
A randomized comparison of antiplatelet and anticoagulant therapy
after the placement of coronary-artery stents. N Engl J Med. 1996;
334:1084-9.
113. Tanguay JF, Zidar JP, Phillips HR, 3rd, Stack RS. Current status of
biodegradable stents. Cardiol Clin. 1994; 12:699-713.
73